Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance | Zendy

Shashikant Srivastava | Zendy; Devyani Deshpande | Zendy; Tawanda Gumbo | Zendy

Open Access

Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance

Author(s) -

Shashikant Srivastava,

Devyani Deshpande,

Tawanda Gumbo

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx303

Subject(s) - ethambutol , regimen , azithromycin , combination therapy , medicine , mycobacterium avium complex , drug resistance , population , pharmacology , antibacterial agent , mycobacterium tuberculosis , antibiotics , tuberculosis , microbiology and biotechnology , biology , pathology , environmental health

To investigate the performance of the two backbone drugs in the standard combination therapy regimen in the hollow-fibre system (HFS) model of pulmonary Mycobacterium avium complex (MAC) infection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research